Intravenous Phenoxybenzamine Use in Pediatric Patients Undergoing Open-Heart Surgery

PHASE2CompletedINTERVENTIONAL
Enrollment

785

Participants

Timeline

Start Date

February 28, 2001

Primary Completion Date

August 31, 2010

Study Completion Date

August 31, 2010

Conditions
Open-heart SurgeryCardiopulmonary Bypass
Interventions
DRUG

Phenoxybenzamine

0.125 to 1 mg/kg given i.v. over 15 to 45 minutes in preparation for cardiopulmonary bypass; may be continued at 0.125 mg/kg/day in ICU

Trial Locations (1)

72207

Arkansas Children's Hospital, Little Rock

All Listed Sponsors
collaborator

Arkansas Children's Hospital Research Institute

OTHER

lead

University of Arkansas

OTHER

NCT00569855 - Intravenous Phenoxybenzamine Use in Pediatric Patients Undergoing Open-Heart Surgery | Biotech Hunter | Biotech Hunter